Author Correction: Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Author Correction: Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers ; volume:14 ; number:1 ; day:3 ; month:7 ; year:2024 ; pages:1 ; date:12.2024
Scientific reports ; 14, Heft 1 (3.7.2024), 1, 12.2024

Creator: Rykkelid, Anne Marit
Sinha, Priyanshu Manojkumar
Folefac, Charlemagne Asonganyi
Horsman, Michael R.
Sørensen, Brita Singers
Søland, Tine Merete
Schreurs, Olaf Joseph Franciscus
Malinen, Eirik
Edin, Nina Frederike J.

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-024-66148-0

URN: urn:nbn:de:101:1-2409231221209.958871018728

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Rykkelid, Anne Marit
Sinha, Priyanshu Manojkumar
Folefac, Charlemagne Asonganyi
Horsman, Michael R.
Sørensen, Brita Singers
Søland, Tine Merete
Schreurs, Olaf Joseph Franciscus
Malinen, Eirik
Edin, Nina Frederike J.
SpringerLink (Online service)

Other Objects (12)

Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers

Hochschulschrift

Regulation of PD-L1 by PPARg for immunotherapy in gastrointestinal cancers

Immunotherapy in Rare Cancers

Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers

Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers

Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1

Immunotherapy : new options in gastrointestinal cancers?

PD-L1 degradation pathway and immunotherapy for cancer

Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth

Regulatory mechanisms of PD-1/PD-L1 in cancers

Clinical applications of PD-L1 bioassays for cancer immunotherapy

Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers

Hochschulschrift

Regulation of PD-L1 by PPARg for immunotherapy in gastrointestinal cancers

Immunotherapy in Rare Cancers

Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers

Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers

Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1

Immunotherapy : new options in gastrointestinal cancers?

PD-L1 degradation pathway and immunotherapy for cancer

Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth

Regulatory mechanisms of PD-1/PD-L1 in cancers

Clinical applications of PD-L1 bioassays for cancer immunotherapy

Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers

Hochschulschrift

Regulation of PD-L1 by PPARg for immunotherapy in gastrointestinal cancers

Immunotherapy in Rare Cancers

Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers

Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers

Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1

Immunotherapy : new options in gastrointestinal cancers?

PD-L1 degradation pathway and immunotherapy for cancer

Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth

Regulatory mechanisms of PD-1/PD-L1 in cancers

Clinical applications of PD-L1 bioassays for cancer immunotherapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Author Correction: Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers

Regulation of PD-L1 by PPARg for immunotherapy in gastrointestinal cancers

Immunotherapy in Rare Cancers

Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers

Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers

Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1

Immunotherapy : new options in gastrointestinal cancers?

PD-L1 degradation pathway and immunotherapy for cancer

Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth

Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth

Regulatory mechanisms of PD-1/PD-L1 in cancers

Clinical applications of PD-L1 bioassays for cancer immunotherapy

Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers

Regulation of PD-L1 by PPARg for immunotherapy in gastrointestinal cancers

Immunotherapy in Rare Cancers

Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers

Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers

Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1

Immunotherapy : new options in gastrointestinal cancers?

PD-L1 degradation pathway and immunotherapy for cancer

Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth

Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth

Regulatory mechanisms of PD-1/PD-L1 in cancers

Clinical applications of PD-L1 bioassays for cancer immunotherapy

Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers

Regulation of PD-L1 by PPARg for immunotherapy in gastrointestinal cancers

Immunotherapy in Rare Cancers

Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers

Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers

Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1

Immunotherapy : new options in gastrointestinal cancers?

PD-L1 degradation pathway and immunotherapy for cancer

Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth

Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth

Regulatory mechanisms of PD-1/PD-L1 in cancers

Clinical applications of PD-L1 bioassays for cancer immunotherapy

Related objects

Reset password